Bottles in a lab

Masitinib

Masitinib (also known as AB1010) is an oral treatment being developed for progressive MS by AB Science. It's being tested in a phase 3 trial.

Current phase of trial: phase 3

Type of MS: primary and secondary progressive MS

Find out more about masitinib